Financings in Brief: Possis Medical
This article was originally published in The Gray Sheet
Possis Medical: Nets about $23.6 mil. from a public offering of 1.9 mil. shares of common at $14.50 per share including 160,000 shares offered by selling shareholders. Plans for the offering were announced during the summer ("The Gray Sheet" Sept. 11, p. 13)...
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.